カテゴリ： QYResearch, 世界, 医療/バイオ

分散型臨床試験（DCT）の世界市場2025年：インターベンショナル、オブザーバー、エクスパンデッドアクセス

■ 英語タイトル：Global Decentralized Clinical Trials (DCTs) Market Research Report 2025

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7455）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7455
■ 発行日：2025年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：92
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥417,600見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥626,400見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥835,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[分散型臨床試験（DCT）の世界市場2025年：インターベンショナル、オブザーバー、エクスパンデッドアクセス]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は分散型臨床試験（DCT）のグローバル市場について調査・分析し、世界の分散型臨床試験（DCT）市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（インターベンショナル、オブザーバー、エクスパンデッドアクセス）、用途別セグメント分析（がん、循環器、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Medidata、IQVIA、Labcorp、PRA Health Sciences、Parexel、ICON、Oracle、CRF Health、Clinical Ink、Medable、Science 37などが含まれています。分散型臨床試験（DCT）のグローバル市場は、2024年にXXX米ドル、2031年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。貿易戦争とロシア・ウクライナ戦争の影響は、分散型臨床試験（DCT）市場規模を算出する際に考慮しました。

・分散型臨床試験（DCT）市場の概要
- 分散型臨床試験（DCT）の種類別セグメント
- 世界の分散型臨床試験（DCT）市場規模：タイプ別分析（インターベンショナル、オブザーバー、エクスパンデッドアクセス）
- 分散型臨床試験（DCT）の用途別セグメント
- 世界の分散型臨床試験（DCT）市場規模：用途別分析（がん、循環器、その他）
- 世界の分散型臨床試験（DCT）市場規模予測（2020年-2031年）

・分散型臨床試験（DCT）市場の成長トレンド
- 分散型臨床試験（DCT）の地域別市場規模（2020年-2031年）
- 分散型臨床試験（DCT）市場ダイナミクス
- 分散型臨床試験（DCT）の業界動向
- 分散型臨床試験（DCT）市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：インターベンショナル、オブザーバー、エクスパンデッドアクセス
- 世界の分散型臨床試験（DCT）のタイプ別市場規模（2020年-2025年）
- 世界の分散型臨床試験（DCT）のタイプ別市場規模（2024年-2029年）

・用途別セグメント：がん、循環器、その他
- 世界の分散型臨床試験（DCT）の用途別市場規模（2020年-2025年）
- 世界の分散型臨床試験（DCT）の用途別市場規模（2024年-2029年）

・分散型臨床試験（DCT）の地域別市場規模
- 北米の分散型臨床試験（DCT）市場規模（2020年-2031年）
- 米国の分散型臨床試験（DCT）市場規模（2020年-2031年）
- ヨーロッパの分散型臨床試験（DCT）市場規模（2020年-2031年）
- アジア太平洋の分散型臨床試験（DCT）市場規模（2020年-2031年）
- 中国の分散型臨床試験（DCT）市場規模（2020年-2031年）
- 日本の分散型臨床試験（DCT）市場規模（2020年-2031年）
- 韓国の分散型臨床試験（DCT）市場規模（2020年-2031年）
- インドの分散型臨床試験（DCT）市場規模（2020年-2031年）
- オーストラリアの分散型臨床試験（DCT）市場規模（2020年-2031年）
- 中南米の分散型臨床試験（DCT）市場規模（2020年-2031年）
- 中東・アフリカの分散型臨床試験（DCT）市場規模（2020年-2031年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Medidata、IQVIA、Labcorp、PRA Health Sciences、Parexel、ICON、Oracle、CRF Health、Clinical Ink、Medable、Science 37

・アナリストの観点/結論

・調査手法と情報源

The FDA defines decentralized clinical trials as those executed through telemedicine and mobile or local healthcare providers, using processes and technologies that differ from the traditional clinical trial model.
Decentralized clinical trials are conducted remotely, with patient subjects remaining at home during a significant portion, or all, of the study. However, the decentralized clinical trial model is designed for more just patient participants.
Highlights
The global Decentralized Clinical Trials (DCTs) market was valued at US$ 8280.7 million in 2024 and is anticipated to reach US$ 18950 million by 2031, witnessing a CAGR of 14.8% during the forecast period 2025-2031. The influence of trade war and the Russia-Ukraine War were considered while estimating market sizes.
Global Decentralized Clinical Trials (DCTs) key players include Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, etc. Global top five manufacturers hold a share over 45%.
North America is the largest production region, with a share about 60%, followed by Europe and Asia-Pacific, both have a share over 30 percent. In terms of product, Interventional is the largest segment, with a share over 45%. And in terms of application, the largest application is Oncology, followed by Cardiovascular, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Decentralized Clinical Trials (DCTs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Decentralized Clinical Trials (DCTs).
The Decentralized Clinical Trials (DCTs) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Decentralized Clinical Trials (DCTs) market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Decentralized Clinical Trials (DCTs) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Medidata
IQVIA
Labcorp
PRA Health Sciences
Parexel
ICON
Oracle
CRF Health
Clinical Ink
Medable
Science 37
Segment by Type
Interventional
Observational
Expanded Access
Segment by Application
Oncology
Cardiovascular
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Decentralized Clinical Trials (DCTs) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Interventional
1.2.3 Observational
1.2.4 Expanded Access
1.3 Market by Application
1.3.1 Global Decentralized Clinical Trials (DCTs) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Decentralized Clinical Trials (DCTs) Market Perspective (2020-2031)
2.2 Decentralized Clinical Trials (DCTs) Growth Trends by Region
2.2.1 Global Decentralized Clinical Trials (DCTs) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Decentralized Clinical Trials (DCTs) Historic Market Size by Region (2020-2025)
2.2.3 Decentralized Clinical Trials (DCTs) Forecasted Market Size by Region (2026-2031)
2.3 Decentralized Clinical Trials (DCTs) Market Dynamics
2.3.1 Decentralized Clinical Trials (DCTs) Industry Trends
2.3.2 Decentralized Clinical Trials (DCTs) Market Drivers
2.3.3 Decentralized Clinical Trials (DCTs) Market Challenges
2.3.4 Decentralized Clinical Trials (DCTs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Decentralized Clinical Trials (DCTs) Players by Revenue
3.1.1 Global Top Decentralized Clinical Trials (DCTs) Players by Revenue (2020-2025)
3.1.2 Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Players (2020-2025)
3.2 Global Decentralized Clinical Trials (DCTs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Decentralized Clinical Trials (DCTs) Revenue
3.4 Global Decentralized Clinical Trials (DCTs) Market Concentration Ratio
3.4.1 Global Decentralized Clinical Trials (DCTs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Decentralized Clinical Trials (DCTs) Revenue in 2022
3.5 Decentralized Clinical Trials (DCTs) Key Players Head office and Area Served
3.6 Key Players Decentralized Clinical Trials (DCTs) Product Solution and Service
3.7 Date of Enter into Decentralized Clinical Trials (DCTs) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Decentralized Clinical Trials (DCTs) Breakdown Data by Type
4.1 Global Decentralized Clinical Trials (DCTs) Historic Market Size by Type (2020-2025)
4.2 Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Type (2026-2031)
5 Decentralized Clinical Trials (DCTs) Breakdown Data by Application
5.1 Global Decentralized Clinical Trials (DCTs) Historic Market Size by Application (2020-2025)
5.2 Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Decentralized Clinical Trials (DCTs) Market Size (2020-2031)
6.2 North America Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Decentralized Clinical Trials (DCTs) Market Size by Country (2020-2025)
6.4 North America Decentralized Clinical Trials (DCTs) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Decentralized Clinical Trials (DCTs) Market Size (2020-2031)
7.2 Europe Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2020-2025)
7.4 Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size (2020-2031)
8.2 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region (2020-2025)
8.4 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Decentralized Clinical Trials (DCTs) Market Size (2020-2031)
9.2 Latin America Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2020-2025)
9.4 Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size (2020-2031)
10.2 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2020-2025)
10.4 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medidata
11.1.1 Medidata Company Detail
11.1.2 Medidata Business Overview
11.1.3 Medidata Decentralized Clinical Trials (DCTs) Introduction
11.1.4 Medidata Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
11.1.5 Medidata Recent Development
11.2 IQVIA
11.2.1 IQVIA Company Detail
11.2.2 IQVIA Business Overview
11.2.3 IQVIA Decentralized Clinical Trials (DCTs) Introduction
11.2.4 IQVIA Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
11.2.5 IQVIA Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Detail
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Decentralized Clinical Trials (DCTs) Introduction
11.3.4 Labcorp Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
11.3.5 Labcorp Recent Development
11.4 PRA Health Sciences
11.4.1 PRA Health Sciences Company Detail
11.4.2 PRA Health Sciences Business Overview
11.4.3 PRA Health Sciences Decentralized Clinical Trials (DCTs) Introduction
11.4.4 PRA Health Sciences Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
11.4.5 PRA Health Sciences Recent Development
11.5 Parexel
11.5.1 Parexel Company Detail
11.5.2 Parexel Business Overview
11.5.3 Parexel Decentralized Clinical Trials (DCTs) Introduction
11.5.4 Parexel Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
11.5.5 Parexel Recent Development
11.6 ICON
11.6.1 ICON Company Detail
11.6.2 ICON Business Overview
11.6.3 ICON Decentralized Clinical Trials (DCTs) Introduction
11.6.4 ICON Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
11.6.5 ICON Recent Development
11.7 Oracle
11.7.1 Oracle Company Detail
11.7.2 Oracle Business Overview
11.7.3 Oracle Decentralized Clinical Trials (DCTs) Introduction
11.7.4 Oracle Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
11.7.5 Oracle Recent Development
11.8 CRF Health
11.8.1 CRF Health Company Detail
11.8.2 CRF Health Business Overview
11.8.3 CRF Health Decentralized Clinical Trials (DCTs) Introduction
11.8.4 CRF Health Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
11.8.5 CRF Health Recent Development
11.9 Clinical Ink
11.9.1 Clinical Ink Company Detail
11.9.2 Clinical Ink Business Overview
11.9.3 Clinical Ink Decentralized Clinical Trials (DCTs) Introduction
11.9.4 Clinical Ink Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
11.9.5 Clinical Ink Recent Development
11.10 Medable
11.10.1 Medable Company Detail
11.10.2 Medable Business Overview
11.10.3 Medable Decentralized Clinical Trials (DCTs) Introduction
11.10.4 Medable Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
11.10.5 Medable Recent Development
11.11 Science 37
11.11.1 Science 37 Company Detail
11.11.2 Science 37 Business Overview
11.11.3 Science 37 Decentralized Clinical Trials (DCTs) Introduction
11.11.4 Science 37 Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
11.11.5 Science 37 Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Interventional
Table 3. Key Players of Observational
Table 4. Key Players of Expanded Access
Table 5. Global Decentralized Clinical Trials (DCTs) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Decentralized Clinical Trials (DCTs) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Decentralized Clinical Trials (DCTs) Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Decentralized Clinical Trials (DCTs) Market Share by Region (2020-2025)
Table 9. Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Decentralized Clinical Trials (DCTs) Market Share by Region (2026-2031)
Table 11. Decentralized Clinical Trials (DCTs) Market Trends
Table 12. Decentralized Clinical Trials (DCTs) Market Drivers
Table 13. Decentralized Clinical Trials (DCTs) Market Challenges
Table 14. Decentralized Clinical Trials (DCTs) Market Restraints
Table 15. Global Decentralized Clinical Trials (DCTs) Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Decentralized Clinical Trials (DCTs) Market Share by Players (2020-2025)
Table 17. Global Top Decentralized Clinical Trials (DCTs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Decentralized Clinical Trials (DCTs) as of 2022)
Table 18. Ranking of Global Top Decentralized Clinical Trials (DCTs) Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Decentralized Clinical Trials (DCTs) Revenue (CR5 and HHI) & (2020-2025)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Decentralized Clinical Trials (DCTs) Product Solution and Service
Table 22. Date of Enter into Decentralized Clinical Trials (DCTs) Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Decentralized Clinical Trials (DCTs) Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Type (2020-2025)
Table 26. Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Type (2026-2031)
Table 28. Global Decentralized Clinical Trials (DCTs) Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Application (2020-2025)
Table 30. Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Application (2026-2031)
Table 32. North America Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Decentralized Clinical Trials (DCTs) Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Decentralized Clinical Trials (DCTs) Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2026-2031) & (US$ Million)
Table 47. Medidata Company Detail
Table 48. Medidata Business Overview
Table 49. Medidata Decentralized Clinical Trials (DCTs) Product
Table 50. Medidata Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
Table 51. Medidata Recent Development
Table 52. IQVIA Company Detail
Table 53. IQVIA Business Overview
Table 54. IQVIA Decentralized Clinical Trials (DCTs) Product
Table 55. IQVIA Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
Table 56. IQVIA Recent Development
Table 57. Labcorp Company Detail
Table 58. Labcorp Business Overview
Table 59. Labcorp Decentralized Clinical Trials (DCTs) Product
Table 60. Labcorp Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
Table 61. Labcorp Recent Development
Table 62. PRA Health Sciences Company Detail
Table 63. PRA Health Sciences Business Overview
Table 64. PRA Health Sciences Decentralized Clinical Trials (DCTs) Product
Table 65. PRA Health Sciences Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
Table 66. PRA Health Sciences Recent Development
Table 67. Parexel Company Detail
Table 68. Parexel Business Overview
Table 69. Parexel Decentralized Clinical Trials (DCTs) Product
Table 70. Parexel Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
Table 71. Parexel Recent Development
Table 72. ICON Company Detail
Table 73. ICON Business Overview
Table 74. ICON Decentralized Clinical Trials (DCTs) Product
Table 75. ICON Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
Table 76. ICON Recent Development
Table 77. Oracle Company Detail
Table 78. Oracle Business Overview
Table 79. Oracle Decentralized Clinical Trials (DCTs) Product
Table 80. Oracle Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
Table 81. Oracle Recent Development
Table 82. CRF Health Company Detail
Table 83. CRF Health Business Overview
Table 84. CRF Health Decentralized Clinical Trials (DCTs) Product
Table 85. CRF Health Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
Table 86. CRF Health Recent Development
Table 87. Clinical Ink Company Detail
Table 88. Clinical Ink Business Overview
Table 89. Clinical Ink Decentralized Clinical Trials (DCTs) Product
Table 90. Clinical Ink Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
Table 91. Clinical Ink Recent Development
Table 92. Medable Company Detail
Table 93. Medable Business Overview
Table 94. Medable Decentralized Clinical Trials (DCTs) Product
Table 95. Medable Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
Table 96. Medable Recent Development
Table 97. Science 37 Company Detail
Table 98. Science 37 Business Overview
Table 99. Science 37 Decentralized Clinical Trials (DCTs) Product
Table 100. Science 37 Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
Table 101. Science 37 Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Decentralized Clinical Trials (DCTs) Market Size Comparison by Type (2025-2031) & (US$ Million)
Figure 2. Global Decentralized Clinical Trials (DCTs) Market Share by Type: 2022 VS 2029
Figure 3. Interventional Features
Figure 4. Observational Features
Figure 5. Expanded Access Features
Figure 6. Global Decentralized Clinical Trials (DCTs) Market Size Comparison by Application (2025-2031) & (US$ Million)
Figure 7. Global Decentralized Clinical Trials (DCTs) Market Share by Application: 2022 VS 2029
Figure 8. Oncology Case Studies
Figure 9. Cardiovascular Case Studies
Figure 10. Others Case Studies
Figure 11. Decentralized Clinical Trials (DCTs) Report Years Considered
Figure 12. Global Decentralized Clinical Trials (DCTs) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Decentralized Clinical Trials (DCTs) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Decentralized Clinical Trials (DCTs) Market Share by Region: 2022 VS 2029
Figure 15. Global Decentralized Clinical Trials (DCTs) Market Share by Players in 2024
Figure 16. Global Top Decentralized Clinical Trials (DCTs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Decentralized Clinical Trials (DCTs) as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Decentralized Clinical Trials (DCTs) Revenue in 2024
Figure 18. North America Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Decentralized Clinical Trials (DCTs) Market Share by Country (2020-2031)
Figure 20. United States Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Decentralized Clinical Trials (DCTs) Market Share by Country (2020-2031)
Figure 24. Germany Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Decentralized Clinical Trials (DCTs) Market Share by Region (2020-2031)
Figure 32. China Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Decentralized Clinical Trials (DCTs) Market Share by Country (2020-2031)
Figure 40. Mexico Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Decentralized Clinical Trials (DCTs) Market Share by Country (2020-2031)
Figure 44. Turkey Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Medidata Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
Figure 47. IQVIA Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
Figure 48. Labcorp Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
Figure 49. PRA Health Sciences Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
Figure 50. Parexel Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
Figure 51. ICON Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
Figure 52. Oracle Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
Figure 53. CRF Health Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
Figure 54. Clinical Ink Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
Figure 55. Medable Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
Figure 56. Science 37 Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

※参考情報

分散型臨床試験（DCT）は、従来の臨床試験の枠組みを超えて新たなアプローチを提案するものであり、医薬品の開発や治療法の検証において、より柔軟でアクセスしやすい方法を提供します。DCTの概念は、試験の実施場所を従来の医療機関から参加者の自宅や地域の医療施設に広げ、参加者がよりリラックスした環境で試験に参加できるようにすることを目指しています。

DCTの定義として、分散型臨床試験とは、試験の多くの部分がリモートで行われ、地理的な制約を緩和することによって、参加者の利便性を高める試験形式を指します。このアプローチは、特に慢性疾患や希少疾患の治療法の検証において、参加者募集の課題を解決するために重要です。

DCTの特徴は多岐にわたります。一つは、リモートデータ収集の利用です。デジタル技術を活用して、参加者からリアルタイムでデータを収集するため、現場訪問の必要性が減ります。これにより、参加者への負担が軽減され、実際の利用環境に即したデータを得ることができます。また、複数の地点から参加者を募集することで、より多様な人口集団を対象とした試験が可能になります。

さらに、DCTはテクノロジーの進化によって支えられています。スマートフォンアプリやウェアラブルデバイス、リモートモニタリング技術などが活用され、被験者は日常生活の中でデータを簡単に提供することができます。また、テレメディスン（遠隔医療）の技術を用いた診察やサポートも重要な要素です。これら技術を活用することで、医療提供者と参加者のインタラクションを強化し、試験の質を向上させることができます。

DCTの種類にはいくつかのバリエーションがあり、主に「おもてなし型」と「参加型」の2つに分類されます。おもてなし型のDCTは、参加者が特に医療機関に出向くことなく、全ての手続きを自宅で行える形式です。一方、参加型のDCTでは、参加者が必要に応じて医療機関を訪れることもありますが、その訪問は従来の試験に比べて大幅に少なくなります。このような二つの形式は、参加者のニーズや病状に応じて使い分けられます。

DCTの用途は主に、医薬品開発、ワクチンの試験、安全性の評価、慢性疾患の管理など多岐にわたります。特にCOVID-19のパンデミックの影響で、DCTの利用が急速に拡大したことからも、リモートでのデータ収集や評価の重要性が再認識されています。例えば、新しいワクチンの臨床試験では、迅速なデータ収集と早期の結果分析が求められています。

DCTの導入にはいくつかの課題も存在します。例えば、デジタルデバイスの利用が前提となるため、高齢者やテクノロジーに不慣れな参加者にとっては参与が難しいこともあります。また、データのプライバシーやセキュリティに関する懸念もあり、適切なデータ管理や倫理的配慮が求められます。

ただし、これらの課題に対する解決策も模索されています。教育プログラムやサポートシステムを通じて、参加者が技術を使いこなせるようにすることが重要です。また、データの安全性を確保するために、厳格なセキュリティプロトコルの導入が必要です。

今後、DCTは医療分野においてますます重要な役割を果たすと考えられます。魅力的な治療法が迅速に市場に投入されることを促進し、参加者のニーズに応じた柔軟な試験設計が可能になります。このように、分散型臨床試験は今後の医薬品開発や健康管理において、革新をもたらす重要な手段となるでしょう。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

※関連データはありません。

※注目の調査資料
 ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(QYR23MA7455 )"分散型臨床試験（DCT）の世界市場2025年：インターベンショナル、オブザーバー、エクスパンデッドアクセス" (英文：Global Decentralized Clinical Trials (DCTs) Market Research Report 2025)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

◆H&Iグローバルリサーチのお客様（例）◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。